Picture of Lovesac Co logo

LOVE Lovesac Co News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer CyclicalsAdventurousSmall CapSuper Stock

Brief: Cannara Biotech Posts Q2 Net Revenue Of $13 Mln

April 24 (Reuters) - Lovesac Co  LOVE.O :
    * CANNARA BIOTECH INC. REPORTS Q2 2023 FINANCIAL RESULTS
WITH
QUARTERLY NET REVENUES OF $13 MILLION, A 76% INCREASE COMPARED
TO Q2 2022
    * CANNARA BIOTECH INC - Q2 2023 NET REVENUE OF $13 MILLION
    * CANNARA BIOTECH INC - COMPANY HAS $25.6 MILLION IN WORKING
CAPITAL AS OF FEBRUARY 28, 2023, WHICH INCLUDES $4.1 MILLION OF
CASH ON HAND

Source text for Eikon:  ID:nCNW6f7PVa 
Further company coverage:  LOVE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lovesac Co

See all news